Heart Failure and Diabetes Mellitus: Biomarkers in Risk Stratification and Prognostication by Michael Lichtenauer, Peter Jirak, Vera Paar, Brigitte Sipos, Kristen Kopp, Alexander E. Berezin

Get full text

How Do Cardiovascular Biomarkers Behave in Patients with Severe Aortic Valve Stenosis with and without Echocardiographically Proven Pulmonary Hypertension?—A Retrospective Study of... by Elke Boxhammer, Lukas Schmidbauer, Moritz Mirna, Vera Paar, Matthias Hammerer, Uta C. Hoppe, Michael Lichtenauer

Get full text

MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future? by Moritz Mirna, Vera Paar, Richard Rezar, Albert Topf, Miriam Eber, Uta C. Hoppe, Michael Lichtenauer, Christian Jung

Get full text

Promising Novel Biomarkers in Cardiovascular Diseases by Brigitte Sipos, Peter Jirak, Vera Paar, Richard Rezar, Moritz Mirna, Kristen Kopp, Uta C. Hoppe, Alexander E. Berezin, Michael Lichtenauer

Get full text

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events by Albert Topf, Moritz Mirna, Nina Bacher, Vera Paar, Christoph Edlinger, Lukas J. Motloch, Sarah Gharibeh, Marwin Bannehr, Uta C. Hoppe, Michael Lichtenauer

Get full text

Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation by Marwin Bannehr, MD, Christian Georgi, MD, Christoph Edlinger, MD, Vera Paar, PhD, Paulina Jankowska, MD, Michael Lichtenauer, MD, Anja Haase-Fielitz, PhD, Martin Seifert, MD, Christian Butter, MD

Get full text

Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest by Richard Rezar, Michael Lichtenauer, Vera Paar, Adrienne Aszlan, Thomas M. Hofbauer, Reinhard Kaufmann, Sarah Wernly, Clemens Seelmaier, Moritz Mirna, Andreas Mangold, Irene M. Lang, Uta C. Hoppe, Anna S. Ondracek, Bernhard Wernly

Get full text

MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction by Elke Boxhammer, Vera Paar, Bernhard Wernly, Attila Kiss, Moritz Mirna, Achim Aigner, Eylem Acar, Simon Watzinger, Bruno K. Podesser, Roland Zauner, Verena Wally, Michael Ablinger, Matthias Hackl, Uta C. Hoppe, Michael Lichtenauer

Get full text

sST2 Predicts Short Term Therapy Success in Patients with Therapy Resistant Hypertension after Renal Sympathetic Denervation by Albert Topf, Vera Paar, Janine Grueninger, Bernhard Wernly, Kristen Kopp, Thomas Weber, Christiana Schernthaner, Moritz Mirna, Sarah X. Gharibeh, Robert Larbig, Rudin Pistulli, Uta C. Hoppe, Michael Lichtenauer, Lukas J. Motloch, Mathias C. Brandt

Get full text

A Comparative Analysis of Novel Biomarkers in Sepsis and Cardiovascular Disease by Peter Jirak, Franz Haertel, Moritz Mirna, Richard Rezar, Michael Lichtenauer, Vera Paar, Lukas J. Motloch, Albert Topf, Atilla Yilmaz, Uta C. Hoppe, P. Christian Schulze, Sebastian Nuding, Karl Werdan, Daniel Kretzschmar, Rudin Pistulli, Henning Ebelt

Get full text

Anti-CD3 Antibody Treatment Reduces Scar Formation in a Rat Model of Myocardial Infarction by Bernhard Wernly, Vera Paar, Achim Aigner, Patrick M Pilz, Bruno K Podesser, Martin Förster, Christian Jung, Josefina Pinon Hofbauer, Birgit Tockner, Monika Wimmer, Theo Kraus, Lukas J Motloch, Matthias Hackl, Uta C Hoppe, Attila Kiss, Michael Lichtenauer

Get full text

Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypert... by Vera Paar, Michael Haslinger, Philipp Krombholz-Reindl, Stefan Pittner, Matthias Neuner, Peter Jirak, Peter Jirak, Tobias Kolbitsch, Bernd Minnich, Falk Schrödl, Alexandra Kaser-Eichberger, Kristen Kopp, Andreas Koller, Clemens Steinwender, Michael Lichtenauer, Fabio C. Monticelli, Rainald Seitelberger, Uta C. Hoppe, Christian Dinges, Lukas J. Motloch, Lukas J. Motloch, Lukas J. Motloch

Get full text